Results 91 to 100 of about 7,521 (213)
Journal of Viral Hepatitis, Volume 32, Issue 12, December 2025.ABSTRACT Characterisation of people with hepatitis B (PwHB) remains limited, particularly regarding treatment status, disease severity and biomarker profiles. Quantitative hepatitis B surface antigen (qHBsAg) is a key predictor of response to emerging therapies, but its distribution is poorly described.
Myriam Drysdale +21 more
wiley +1 more source
Virology Journal, 2011 Background Although entacavir and adefovir were widely used in most Asian countries, there were few conclusions drawn from a meta-analysis for comparing the efficacy between entecavir and adefovir in nucleos(t)ide-naïve Asian patients with chronic ...
Zhao Jun, Liu Weiwei, Zhao Pan, Guan Qun
doaj +1 more source
Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control [PDF]
, 2005 Quantitation of circulating hepatitis B virus (HBV) DNA is important for monitoring disease progression and for assessing the response to antiviral therapy. Several commercial and 'in house' assays for HBV DNA quantitation have been described but many of
Ayliffe, U +4 more
core +1 more source
FIGO good practice recommendations on preconception care: A strategy to prevent preterm birth
International Journal of Gynecology &Obstetrics, Volume 171, Issue 2, Page 574-587, November 2025.Abstract Preterm birth (PTB) remains one of the leading causes of neonatal mortality and long‐term morbidity worldwide, with minimal progress being made in reducing its incidence, particularly in low‐resource settings. Preconception care is recognized as an effective strategy for PTB prevention; however, the fact that more than half of pregnancies ...
Leticia Irma Ojeda +21 more
wiley +1 more source
Infection and Drug Resistance, 2018 Shaohang Cai,* Zhandong Li,* Tao Yu, Muye Xia, Jie Peng Department of Infectious Diseases and Hepatology Unit, NanFang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China *These authors contributed equally to this ...
Cai S, Li Z, Yu T, Xia M, Peng J
doaj
Pharmacology Research &Perspectives, Volume 13, Issue 5, October 2025.ABSTRACT Tenofovir disoproxil fumarate (TDF) and entecavir (ETV) are first‐line antiviral agents for chronic hepatitis B (CHB), yet comparative real‐world data in Southeast Asian populations remain limited. This retrospective cohort study aimed to compare the efficacy, biochemical response, antifibrotic effect, and renal safety of TDF versus ETV in ...
Thong Duy Vo +2 more
wiley +1 more source
PLoS ONE, 2015 The aim of this study was to assess the effect of 48-week entecavir therapy on serum and intrahepatic hepatitis B virus, covalently closed circular DNA (HBV cccDNA) levels in hepatitis B e antigen (HBeAg)-positive patients.
Ming Shi +4 more
doaj +1 more source
Clinical, epidemiological and virological features of acute hepatitis B in Italy [PDF]
, 2015 Purpose To evaluate the association of hepatitis B virus (HBV) genotypes, basal core promoter (BCP)/precore (PC) and S gene mutations with the clinical-epidemiological characteristics of acute hepatitis B (AHB) in Italy.
Alessandro Remo Zanetti +10 more
core +1 more source
The Turkish Journal of Gastroenterology, 2015 Background/Aims: We aimed to investigate the clinical importance of quantitative levels of serum hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg), and to detect their correlation with hepatitis B virus (HBV) DNA load, alanine ...
Kaan Demirören +2 more
doaj +1 more source
Treatment of HBeAg-Positive Hepatitis B with Peginterferon and Lamivudine: Author's reply [PDF]
, 2005 published_or_final_versio
Lau, GKK +3 more
core